[1]
B. Tunç, M. Gencturk, A. Aktürk, and F. Kantarcı, “Significant Prostate Cancer in Patients with PI-RADS Category 3 Lesions: A Single-Center, Retrospective Cohort Study”, Urol J, vol. 20, no. 05, pp. 329–336, Oct. 2023.